Portfolio Clinic: Our reader has a clear idea of what he wants to do, but isn't sure his strategy will get him there
Over 25 trusts have announced fee reductions over the past year
The Interview: Nick Train talks about AI, foreign investors and why even buy-and-hold managers like himself are busy buying bargains
It could be a good time for long term investors to buy into Aim
Songs fund managed by Merck Mercuriadis will now have to offer shareholders alternative options, inlcuding winding up
There's been a clear preference for stocks and cash-like investments
Another major name is looking to shut up shop
Portfolio Clinic: Our reader has amassed a near-£1mn portfolio but has 55 different funds, trusts and shares
Conservative valuations have hit VCTs' performance but their holdings' revenues are growing
The embattled music royalties fund runs into further trouble